DONATE
DONATE →

Clinical trial 2026-526300-67-00 · Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III)

Strongers editorial cover for clinical study 2026-526300-67-00 (Phase III), status: authorised — Locally Advanced, Unresectable Non-Small Cell Lu.
Oncology research 09 Nov 2026

2026-526300-67-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Clinical trial 2026-526300-67-00 (phase III) is «authorised» on CTIS (EU Clinical Trials Information System).

Condition: Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) · Registered interventions: IMFINZI 50 mg/mL concentrate for solution for infusion, ivonescimab · Recorded dates (source): 2026-11-06, 2026-11-08.

Source: https://euclinicaltrials.eu/ctis-public/view/2026-526300-67-00

A newsletter for those who compete, those who donate, those who believe in research

Events, awarded grants, stories of the people who make research possible. One email a month, no spam.